Implantable Cardioverter Defibrillators (ICDs) Market Report 2026

Implantable Cardioverter Defibrillators (ICDs) Market Overview

• Implantable Cardioverter Defibrillators (ICDs) market size has reached to $3.98 billion in 2025 • Expected to grow to $5.21 billion in 2030 at a compound annual growth rate (CAGR) of 5.5% • Growth Driver: Increasing Prevalence Of Cardiovascular Diseases Driving The Growth Of The Market • Market Trend: Enhancing Device Efficiency and Patient Comfort with Low Current Consumption Defibrillators • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Implantable Cardioverter Defibrillators (ICDs) Market?

Implantable cardioverter defibrillators (ICDs) are small devices implanted under the skin, typically near the chest, designed to monitor the heart's rhythm and deliver electrical shocks if a life-threatening arrhythmia, such as ventricular fibrillation, is detected. Their purpose is to prevent sudden cardiac arrest by restoring a normal heart rhythm. The main types of implantable cardioverter defibrillators (ICDs) are single-chamber implantable cardioverter defibrillators (ICDs), dual-chamber implantable cardioverter defibrillators (ICDs), and biventricular devices. A single-chamber ICD is a device implanted in the chest that detects and corrects abnormal heart rhythms in one chamber of the heart. It is used for various applications, such as bradycardia, tachycardia, heart failure, and other applications by several end users, including hospitals, specialty clinics, ambulatory surgical centers, and other end users.

What Is The Implantable Cardioverter Defibrillators (ICDs) Market Growth Forecast?

The implantable cardioverter defibrillators (icds) market size is expected to see strong growth in the next few years. It will grow to $5.21 billion in 2030 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to technological advancements in smart icds, growing demand for remote patient monitoring, rising geriatric population with cardiac disorders, increasing awareness of preventive cardiac therapies, expansion of reimbursement coverage for implantable devices. Major trends in the forecast period include increasing adoption of remote monitoring enabled icds, rising preference for minimally invasive and wireless icd systems, growing use of mri-compatible implantable devices, expanding indications of icds in heart failure management, increasing integration of predictive analytics in arrhythmia management.

Global Implantable Cardioverter Defibrillators (ICDs) Market Segmentation

1) By Type: Single Chamber Implantable Cardioverter Defibrillators (ICDs), Dual Chamber Implantable Cardioverter Defibrillators (ICDs), Biventricular Devices 2) By Application: Bradycardia, Tachycardia, Heart Failure, Other Applications 3) By End User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Other End Users Subsegments: 1) By Single Chamber Implantable Cardioverter Defibrillators (ICDs): Standard Single Chamber ICDs, MRI-Compatible Single Chamber ICDs, Wireless Single Chamber ICDs 2) By Dual Chamber Implantable Cardioverter Defibrillators (ICDs): Standard Dual Chamber ICDs, MRI-Compatible Dual Chamber ICDs, Wireless Dual Chamber ICDs 3) By Biventricular Devices: CRT-D (Cardiac Resynchronization Therapy Defibrillator), Biventricular ICDs With Advanced Features (Remote Monitoring, Wireless Capabilities)

What Is The Driver Of The Implantable Cardioverter Defibrillators (ICDs) Market?

The increasing prevalence of cardiovascular diseases (CVDs) is expected to propel the growth of the implantable cardioverter defibrillators (ICDs) market going forward. Cardiovascular diseases (CVDs) are a group of disorders affecting the heart and blood vessels, including conditions such as heart attacks, strokes, and hypertension, often caused by factors like poor diet, lack of exercise, smoking, and genetics. The increasing prevalence of cardiovascular diseases is primarily driven by aging populations, unhealthy lifestyle choices, and rising rates of risk factors such as obesity, diabetes, and hypertension. Implantable cardioverter defibrillators (ICDs) help manage cardiovascular diseases (CVDs) by providing life-saving electrical shocks to restore normal heart rhythms in patients at risk of sudden cardiac arrest. For instance, in October 2024, according to the Centers for Disease Control and Prevention (CDC), a US-based public health agency, 919,032 people died from cardiovascular disease in 2023, accounting for approximately 1 in every 3 deaths in the United States. Therefore, the increasing prevalence of cardiovascular diseases (CVDs) is driving the growth of the implantable cardioverter defibrillators (ICDs) industry.

Key Players In The Global Implantable Cardioverter Defibrillators (ICDs) Market

Major companies operating in the implantable cardioverter defibrillators (icds) market are Abbott Laboratories, Medtronic Inc., Boston Scientific Corporation, St. Jude Medical Inc., BIOTRONIK SE & Co. KG, LivaNova PLC, MicroPort Scientific Corporation, Intermedics Inc., Sorin Group S.p.A.

Global Implantable Cardioverter Defibrillators (ICDs) Market Trends and Insights

Major companies operating in the implantable cardioverter defibrillators (ICDs) market are focusing on technological advancements, such as low current consumption defibrillators, to enhance device efficiency, extend battery life, and improve patient comfort. Low current consumption defibrillators are designed to deliver electrical shocks to the heart using less energy, which helps prolong battery life while ensuring effective treatment of arrhythmias. For instance, in October 2023, MicroPort CRM, a France-based medical devices company, launched the ULYS implantable cardioverter defibrillator (ICD) and the INVICTA defibrillation lead in Japan, marking a notable advancement in cardiac care technology. These devices feature innovative capabilities, such as low current consumption for prolonged battery life and MRI compatibility, ensuring they are suitable for patients needing imaging procedures. The ULYS ICD includes the PARAD+ arrhythmia discrimination algorithm and AutoMRI functionality, enhancing patient safety during MRI scans. Additionally, the INVICTA lead achieved a 100% implantation success rate and a 97.4% complication-free rate in clinical trials, highlighting its reliability and effectiveness.

What Are Latest Mergers And Acquisitions In The Implantable Cardioverter Defibrillators (ICDs) Market?

In June 2023, Royal Philips, a Netherlands-based health technology company, partnered with Biotronik to expand the cardiovascular device offerings available to customers of Philips SymphonySuite, a leading solution for cardiovascular office-based labs (OBLs) and ambulatory surgery centers (ASCs). By integrating Philips SymphonySuite with BIOTRONIK's extensive range of cardiac rhythm management and cardiovascular intervention products, the partnership enhances options for personalized patient care and supports the growing trend toward out-of-hospital care settings. Biotronik is a US-based medical device company offering products and services that enhance the quality of life for patients with cardiovascular and endovascular diseases.

Regional Outlook

North America was the largest region in the implantable cardioverter defibrillators market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Implantable Cardioverter Defibrillators (ICDs) Market?

The implantable cardioverter defibrillators (ICDs) market consists of sales of therapy defibrillators, rechargeable and non-rechargeable batteries, programming devices, implantation tools, electrodes, and leads. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Implantable Cardioverter Defibrillators (ICDs) Market Report 2026?

The implantable cardioverter defibrillators (icds) market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the implantable cardioverter defibrillators (icds) industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.